Anika Therapeutics | ANIK - Stock


Anika Therapeutics reported $22.84M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Abbott USD 6.99B 501M Mar/2026
Agios Pharmaceuticals USD 35.09M 2.17M Mar/2026
Anika Therapeutics USD 22.84M 4.05M Mar/2026
Arrowhead Research USD -173.08M 173.08M Dec/2024
Halozyme Therapeutics USD 155.47M 21.01M Mar/2026
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Insmed USD 132.91M 841K Mar/2026
Integra LifeSciences USD 495.04M 2.3M Mar/2026
Intrexon USD 287K 68K Dec/2022
J&J USD 14.58B 392M Mar/2026
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
Ligand Pharmaceuticals USD 13.27M 4.14M Mar/2026
MacroGenics USD 9.5M 1.59M Mar/2026
Merit Medical Systems USD 352.39M 18.68M Mar/2026
Rigel Pharmaceuticals USD 13.3M 2.88M Sep/2025
Sanofi EUR 22.69B 1.81B Dec/2025
Stryker USD 5.42B 109M Mar/2026
Surmodics USD 15.17M 230K Sep/2024
Veracyte USD 21.42M 870K Mar/2026
Zimmer Biomet Holdings USD 2.25B 39.6M Mar/2026